SS
DNA icon

SBI Securities’s Ginkgo Bioworks DNA Stock Holding History

SBI Securities’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$39.4K Buy
3,975
+85
+2% +$711 ﹤0.01% 1262
2026
Q1 		$23.8K Buy
3,890
+220
+6% +$1.83K ﹤0.01% 1389
2025
Q4 		$30.5K Buy
3,670
+34
+0.9% +$366 ﹤0.01% 1279
2025
Q3 		$53K Sell
3,636
-47
-1% -$562 ﹤0.01% 1067
2025
Q2 		$41.4K Buy
3,683
+115
+3% +$891 ﹤0.01% 1122
2025
Q1 		$20.3K Buy
3,568
+663
+23% +$6.75K ﹤0.01% 1321
2024
Q4 		$28.5K Buy
+2,905
New +$24.9K ﹤0.01% 1197

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

SBI Securities's DNA Position: Q2 2026 in Review

SBI Securities increased its Ginkgo Bioworks (DNA) stake by 2.2% in Q2 2026, buying an estimated $711 and bringing the position to 3,975 shares worth $39.4K. The position accounts for ﹤0.01% of the portfolio, ranked #1262.

SBI Securities first reported a position in DNA in Q4 2024 and has held it in 7 quarters since. The position peaked at $53K in Q3 2025. 184 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • SBI Securities held 3,975 shares of Ginkgo Bioworks worth $39.4K as of Q2 2026.
  • SBI Securities bought 85 Ginkgo Bioworks shares in Q2 2026, an estimated $711.
  • Ginkgo Bioworks made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1262 holding.
  • SBI Securities first reported a position in Ginkgo Bioworks in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Ginkgo Bioworks position peaked at $53K in Q3 2025.
  • 184 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.